Target intelligence / Profile preview

Purine-rich element-binding protein B (PURB)

Target
PURB
Molecular classification
Transcription factor, DNA-binding protein, RNA-binding protein
01

Overview

Purine-rich element-binding protein B (PURB) is a sequence-specific, single-stranded DNA-binding protein that preferentially binds to purine-rich elements (PUR elements) found at DNA replication origins and gene flanking regions across eukaryotes. It is a member of the Pur family of transcription factors, sharing structural similarities with PURA. PURB regulates gene expression by acting as a transcriptional activator or repressor, influencing cell differentiation, development (notably in muscle, blood, and brain), and specific cellular processes such as hepatic glucose production and mRNA transport in neurons. It has been specifically noted to regulate the transcription of key genes involved in muscle and smooth muscle cell biology and plays a role in amino acid-induced milk protein and fat synthesis in mammary cells via mTOR and SREBP-1c. Deletions or dysregulation of the PURB gene have been linked to hematological malignancies, especially myelodysplastic syndrome and acute myelogenous leukemia, as well as to neurodevelopmental disorders. PURB has not been identified as a direct target for approved therapeutic drugs and currently does not have characterized pharmacological agents or mechanism-of-action inhibitors.[1][2][3][4][5]

Other names
Transcriptional activator protein Pur-betaPURBETATranscriptional regulator protein Pur-betaPurine-rich element binding protein B
02

Biological functions

Regulation of DNA replicationRegulation of transcriptionRepression of vascular smooth muscle alpha-actin gene transcriptionRegulation of muscle, myeloid cell, and brain developmentmRNA transport in neuronsRegulation of hepatic glucose productionRegulation of mammary epithelial cell milk protein and fat synthesis
03

Disease associations

Cancer (notably myelodysplastic syndrome and acute myelogenous leukemia)Neurodevelopmental disorders (implicated in fragile-X mental retardation syndrome and brain development)Premature aging
04

Biomarkers

Deletion is a biomarker for myelodysplastic syndrome and acute myelogenous leukemia

Beyond the preview

Go deeper on Purine-rich element-binding protein B (PURB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purine-rich element-binding protein B (PURB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call